NZ569936A - 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives - Google Patents

4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives

Info

Publication number
NZ569936A
NZ569936A NZ569936A NZ56993607A NZ569936A NZ 569936 A NZ569936 A NZ 569936A NZ 569936 A NZ569936 A NZ 569936A NZ 56993607 A NZ56993607 A NZ 56993607A NZ 569936 A NZ569936 A NZ 569936A
Authority
NZ
New Zealand
Prior art keywords
salt
compound
hydrate
dimethoxy
phenyl
Prior art date
Application number
NZ569936A
Other languages
English (en)
Inventor
Kazuki Miyazaki
Kazutomi Kusano
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Priority claimed from PCT/JP2007/053066 external-priority patent/WO2007097317A1/ja
Publication of NZ569936A publication Critical patent/NZ569936A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ569936A 2006-02-21 2007-02-20 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives NZ569936A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
PCT/JP2007/053066 WO2007097317A1 (ja) 2006-02-21 2007-02-20 4-(3-ベンゾイルアミノフェニル)-6,7-ジメトキシ-2-メチルアミノキナゾリン誘導体

Publications (1)

Publication Number Publication Date
NZ569936A true NZ569936A (en) 2010-07-30

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ569936A NZ569936A (en) 2006-02-21 2007-02-20 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives

Country Status (18)

Country Link
JP (1) JP4778550B2 (el)
KR (1) KR101278852B1 (el)
AT (1) ATE517875T1 (el)
BR (1) BRPI0708098B8 (el)
CY (1) CY1112554T1 (el)
DK (1) DK1992622T3 (el)
ES (1) ES2368089T3 (el)
HK (1) HK1122025A1 (el)
HR (1) HRP20110604T1 (el)
IL (1) IL193322A (el)
JO (1) JO2726B1 (el)
MY (1) MY146275A (el)
NZ (1) NZ569936A (el)
PT (1) PT1992622E (el)
RS (1) RS51969B (el)
RU (1) RU2431632C2 (el)
SI (1) SI1992622T1 (el)
TW (1) TWI404709B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099887A1 (ja) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. メチル n-[3-(6,7-ジメトキシ-2-メチルアミノキナゾリン-4-イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩
EP2189450B1 (en) 2007-08-17 2011-12-21 Eisai R&D Management Co., Ltd. Method for producing quinazoline derivative
JP5060561B2 (ja) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規外用剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
RU2431632C2 (ru) 2011-10-20
RS51969B (en) 2012-02-29
PT1992622E (pt) 2011-09-19
HK1122025A1 (el) 2009-05-08
TW200812980A (en) 2008-03-16
SI1992622T1 (sl) 2011-11-30
KR20080094811A (ko) 2008-10-24
CY1112554T1 (el) 2016-02-10
TWI404709B (zh) 2013-08-11
DK1992622T3 (da) 2011-09-05
MY146275A (en) 2012-07-31
IL193322A (en) 2014-04-30
BRPI0708098B8 (pt) 2021-05-25
JO2726B1 (en) 2013-09-15
ES2368089T3 (es) 2011-11-14
KR101278852B1 (ko) 2013-07-01
JP4778550B2 (ja) 2011-09-21
BRPI0708098B1 (pt) 2019-08-06
HRP20110604T1 (hr) 2011-09-30
ATE517875T1 (de) 2011-08-15
IL193322A0 (en) 2009-05-04
BRPI0708098A2 (pt) 2011-05-17
RU2008137654A (ru) 2010-03-27
JPWO2007097317A1 (ja) 2009-07-16

Similar Documents

Publication Publication Date Title
US7939540B2 (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
AU2008290001B2 (en) Novel preparation for external use
AU2008215411B2 (en) Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
NZ569936A (en) 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
WO2019206120A1 (zh) 甲酰胺类化合物、其制备方法及其应用
CN109280032B (zh) 一种哒嗪酮母核结构的组蛋白去乙酰化酶抑制剂及其制备方法和用途
JP2012526054A (ja) 複素環置換のジフェニル尿素類誘導体及びその用途
JP6464244B2 (ja) Tert−ブチル n−[2−{4−[6−アミノ−5−(2,4−ジフルオロベンゾイル)−2−オキソピリジン−1(2h)−イル]−3,5−ジフルオロフェニル}エチル)−l−アラニネート又はその製薬上許容され得る塩、水和物もしくは溶媒和物
US20060111368A1 (en) Phosphodiesterase inhibitor
WO2015021833A1 (zh) 共轭双烯衍生物及其制备方法和作为抗癌药物的用途
JP5102230B2 (ja) メチルn−[3−(6,7−ジメトキシ−2−メチルアミノキナゾリン−4−イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩
KR20090118025A (ko) 메틸 n-[3-(6,7-디메톡시-2-메틸아미노퀴나졸린-4-일)페닐]테레프탈람산의 결정, 비정질체 또는 염

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed